Nano Dimension Reports Second Quarter Financial Results

Nano Dimension (TASE:NNDM, NASDAQ:NNDM) ended the second quarter of 2016 with $5,793,000(NIS 22,278,000) in cash and cash equivalents, while total quarterly expenses were $1,664,000(NIS 6,401,000).
Amit Dror, CEO, said, “We made significant progress during the second quarter and look forward to officially launching the company’s sales strategy in the third quarter. The advancements the company has made over the past quarter include additional patent applications, which we believe will help support our vision that our technology may have various uses – from prototypes for electronics to complex structures for different applications across various industries. As we continue to reach ambitious milestones, we are eager to enter this next phase as we will begin to see the full market demand for our revolutionary printer.”
Second Quarter 2016 Financial Results:

• Research and development (R&D) expenses for the second quarter of 2016 were $503,000(NIS 1,933,000), compared to $436,000(NIS 1,642,000) in the first quarter of 2016 and $1,449,000(NIS 5,571,000) in the second quarter of 2015. The increase compared to the first quarter of 2016 was mainly attributable to an increase of $222,000(NIS 855,000) in salaries and related personnel expenses, reflecting an increase in the number of employees (the company had 57 R&D employees as of June 30, 2016 and 46 R&D employees as of March 31, 2016).The R&D expenses for the second quarter of 2016 are presented net of government grants in the amount of $103,000(NIS 398,000) and net of development expenses recognized as intangible assets in the amount of$1,405,000(NIS 5,404,000).
• General and administrative (G&A) expenses for the second quarter of 2016 were $1,197,000(NIS 4,605,000), compared to $1,176,000(NIS 4,429,000) in the first quarter of 2016 and $413,000(NIS 1,590,000) in the second quarter of 2015. The increase compared to the first quarter of 2016 resulted primarily from an increase of $178,000(NIS 683,000) in professional services expenses mainly for investor relations and legal services.
• Net loss for the second quarter of 2016 was $1,664,000(NIS 6,401,000), or $0.04(NIS 0.17) per share, compared to $1,790,000(NIS 6,741,000), or $0.05(NIS 0.18) per share, in the first quarter of 2016 and $1,848,000(NIS 7,109,000), or $0.08(NIS 0.29) per share, in the second quarter of 2015. The change compared to the first quarter of 2016 was due to the changes in the expenses described above, as well as a change in finance expenses due to a change in the exchange rate of the USD against the NIS.

Balance Sheet Highlights

• Cash and cash equivalents totaled $5,793,000(NIS 22,278,000) as of June 30, 2016, compared to $8,665,000(NIS 33,811,000) on December 31, 2015. The decrease compared to December 31, 2015 reflects the cash used in operations during the six-month period ended June 30, 2016, net of proceeds received in respect of government grants and net of proceeds received from exercise of warrants during the period.
• Shareholders’ equity totaled $11,558,000(NIS 44,452,000) as of June 30, 2016, compared to $12,047,000(NIS 47,004,000) on December 31, 2015.

Second Quarter and Recent Corporate Highlights:

• On May 24, 2016, the company announced that it has been included in the “Cool Vendors in 3D Printing, 2016” report by Gartner, Inc.
• On May 25, 2016, the company announced that it has successfully lab-tested a proof of concept 3D bioprinter for stem cells. The trial was conducted in collaboration with Accellta Ltd., a company headquartered in Haifa, Israel, that has developed proprietary technologies for the unique production of high quality media, stem cells, progenitors and differentiated cells for drug discovery, regenerative medicine and research. The feasibility study confirmed that the combined know-how and technologies of the companies enabled printing of viable stem cells using an adapted 3D printer.
• On August 24, 2016, the company announced that it has supplied the first DragonFly 2020 system designated for 3D circuitry and PCBs to a leading defense company in Israel for evaluation purposes. The first supply of the DragonFly 2020 system for testing marked yet another breakthrough for the company. This is the first key step towards the potential commercialization of Nano Dimension’s products.

Connect with Nano Dimension (TASE:NNDM,NASDAQ:NNDM) to receive an Investor Presentation.